Ways Kirk 4
4 · SPRUCE BIOSCIENCES, INC. · Filed Jul 24, 2025
Insider Transaction Report
Form 4
Ways Douglas Kirk
DirectorInterim Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-07-23+30,000→ 30,000 totalExercise: $0.12Exp: 2035-07-22→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2026 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan).